# Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ

> **NCT06414499** · PHASE3 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 1386 (estimated)

## Conditions studied

- Minor Ischemic Stroke

## Interventions

- **DRUG:** rhTNK-tPA
- **DRUG:** Control group (Aspirin combined with clopidogrel)

## Key facts

- **NCT ID:** NCT06414499
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-09
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 1386 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414499, "Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06414499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*